KEGG   DGROUP: Receptor tyrosine kinase inhibitor
Entry
DG01917                     DGroup                                 

Name
Receptor tyrosine kinase inhibitor
Member
D01977  
Gefitinib (JAN/USAN/INN)  <JP/US>
Erlotinib
 D07907  
Erlotinib (INN)
 D04023  
Erlotinib hydrochloride (JAN/USAN)  <JP/US>
Sunitinib
 D08552  
Sunitinib (INN)
 D06402  
Sunitinib malate (JAN/USAN)  <JP/US>
Lapatinib
 D08108  
Lapatinib (INN)
 D04024  
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)  <JP>
D05380  
Pazopanib hydrochloride (JAN/USAN)  <JP/US>
D06407  
Vandetanib (JAN/USAN/INN)  <JP/US>
Afatinib
 D09724  
Afatinib (USAN/INN)
 D09733  
Afatinib dimaleate (USAN); Afatinib maleate (JAN)  <JP/US>
D03218  
Axitinib (JAN/USAN)  <JP/US>
Regorafenib
 D10138  
Regorafenib (USAN/INN)
 D10137  
Regorafenib hydrate (JAN)  <JP/US>
D10229  
Masitinib (INN)
Cabozantinib
 D10062  
Cabozantinib (USAN)
 D10095  
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)  <JP/US>
Lenvatinib
 D09919  
Lenvatinib (USAN/INN)
 D09920  
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)  <JP/US>
Cediranib
 D08881  
Cediranib (USAN/INN)
 D08883  
Cediranib maleate (JAN/USAN)
Tivozanib
 D09683  
Tivozanib (USAN/INN)
 D10190  
Tivozanib hydrochloride (USAN)
D10766  
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)  <JP/US>
D10858  
Rociletinib (USAN/INN)
D05029  
Midostaurin (JAN/USAN/INN)  <US>
Olmutinib
 D10859  
Olmutinib (USAN/INN)
 D11115  
Olmutinib hydrochloride (USAN)
Neratinib
 D08950  
Neratinib (USAN/INN)
 D10898  
Neratinib maleate  <US>
Dacomitinib
 D09883  
Dacomitinib (INN)
 D10514  
Dacomitinib (USAN); Dacomitinib hydrate (JAN)  <JP/US>
D11251  
Icotinib
Quizartinib
 D09955  
Quizartinib (USAN/INN)
 D09956  
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)  <JP>
Larotrectinib
 D11137  
Larotrectinib (USAN/INN)
 D11138  
Larotrectinib sulfate (JAN/USAN)  <US>
Gilteritinib
 D10709  
Gilteritinib (USAN/INN)
 D10800  
Gilteritinib fumarate (JAN/USAN)  <JP/US>
Capmatinib
 D10696  
Capmatinib (USAN/INN)
 D10891  
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN)  <JP/US>
D10927  
Erdafitinib (USAN/INN)  <US>
D11141  
Tucatinib (USAN/INN)  <US>
D11279  
Avapritinib (USAN/INN)  <US>
D11417  
Pemigatinib (JAN/USAN/INN)  <US>
Motesanib
 D06678  
Motesanib (USAN)
 D08947  
Motesanib diphosphate (USAN); Motesanib phosphate (JAN)
Varlitinib
 D09689  
Varlitinib (USAN/INN)
 D09690  
Varlitinib tosylate (USAN)
Crenolanib
 D10102  
Crenolanib (USAN)
 D10103  
Crenolanib besylate (USAN)
Toceranib
 D08503  
Toceranib (USAN)
 D08544  
Toceranib phosphate (USAN)
Golvatinib
 D10224  
Golvatinib (USAN)
 D10465  
Golvatinib tartrate (USAN)
Brivanib
 D09589  
Brivanib (USAN)
 D08878  
Brivanib alaninate (JAN/USAN/INN)
Rivoceranib
 D11288  
Rivoceranib (USAN/INN)
 D11289  
Rivoceranib mesylate (USAN)
Nazartinib
 D11430  
Nazartinib (USAN/INN)
 D11434  
Nazartinib mesylate (USAN)
Sitravatinib
 D11140  
Sitravatinib (USAN/INN)
 D11541  
Sitravatinib malate (USAN)
Infigratinib
 D11589  
Infigratinib (USAN/INN)
 D11611  
Infigratinib phosphate (USAN)
Tepotinib
 D11717  
Tepotinib (USAN/INN)
 D11073  
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)  <JP>
Dubermatinib
 D11732  
Dubermatinib (USAN/INN)
 D11733  
Dubermatinib tartrate (USAN)
Tesevatinib
 D11772  
Tesevatinib (USAN/INN)
 D11773  
Tesevatinib tosylate (USAN)
Naquotinib
 D10958  
Naquotinib (USAN/INN)
 D10886  
Naquotinib mesylate (USAN); Naquotinib mesilate (JAN)
D03350  
Canertinib dihydrochloride (USAN)
D04025  
Mubritinib (USAN/INN)
D04696  
Lestaurtinib (USAN/INN)
D05399  
Pelitinib (USAN/INN)
D05819  
Semaxanib (USAN/INN)
D06005  
Tandutinib (USAN/INN)
D06285  
Vatalanib (USAN/INN)
D08907  
Dovitinib lactate (USAN); Dovitinib lactate hydrate (JAN)
D09618  
Foretinib (USAN/INN)
D09635  
Linifanib (USAN/INN)
D09945  
Pegdinetanib (USAN/INN)
D10173  
Tivantinib (JAN/USAN/INN)
D10862  
Altiratinib (USAN)
D11136  
Glesatinib (USAN/INN)
D11139  
Savolitinib (USAN/INN)
D11353  
Ripretinib (USAN)  <US>
D11368  
Mavelertinib (USAN/INN)
D11438  
Bemcentinib (USAN/INN)
D11461  
Derazantinib hydrochloride (USAN)
D11725  
Futibatinib (JAN/USAN/INN)
D11737  
Fisogatinib (USAN/INN)
 » expand
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
LinkDB

» Japanese version

DBGET integrated database retrieval system